Aptimmune Biologics has completed its Series B funding initiative, raising more than $6 million from several investors. This increases the combined total investment to almost $9 million, generated by the company through three rounds of funding. “Aptimmune is thrilled to receive strong investor support during this critical time in our development,” said Aaron Gilbertie, Aptimmune CEO. “The Series B funds … Read More
Proposed Rule to Modernize Swine Inspection
The USDA’s Food Safety and Inspection Service (FSIS) announced its continued effort to modernize inspection systems through science-based approaches to food safety. USDA is proposing to amend the federal meat inspection regulations to establish a new voluntary inspection system for market hog slaughter establishments called the New Swine Slaughter Inspection System (NSIS), while also requiring additional pathogen sampling for all … Read More
New Swine Inactivated Mucosal Flu A Virus Vaccine from Aptimmune
Aptimmune Biologics introduces the industry’s first inactivated mucosal influenza A virus in swine (IAV-S) vaccine administered via nasal spray. Aptimmune’s IAV-S vaccine utilizes the BARRICADE™ proprietary vaccine formulation that gives swine producers and veterinarians a completely different approach to conventional inactivated injectable and live virus vaccines for safely preventing and managing respiratory disease. This inactivated mucosal vaccine is a new … Read More
Nebraska Farmer Named America’s Pig Farmer of the Year
Leslie McCuiston, a pig farmer from Columbus, Nebraska, has been named the 2017 America’s Pig Farmer of the Year. According to the National Pork Board, the award recognizes a pig farmer who excels at raising pigs using the We Care ethical principles and who connects with today’s consumers about how pork is produced. McCuiston received the highest combined score from … Read More
DSM Introduces Hy•D® for Swine in U.S. Market
DSM has introduced Hy•D® to the U.S. marketing optimizing the genetic potential within in sow herds, and improving the overall nutrition status and profitability. Hy•D is a proprietary metabolite of vitamin D, 25-OH-D3 that supplements vitamin D3. Adding 25-OH-D3 directly into the diet is highly beneficial to animal health and productivity. Hy•D is consistently and efficiently absorbed by the animal, … Read More
U.S. Pork Gains Access to Argentine Market
The National Pork Producers Council (NPPC) applauds the Trump administration for negotiating U.S. pork access to the Argentine market. Argentina was among several countries with non-science based barriers to U.S. pork imports. “U.S. pork producers are the most competitive in the world and we have long sought the opportunity to provide affordable, high-quality pork in Argentina,” said NPPC President Ken … Read More
Aptimmune Biologics Adds Veterinarian to Swine Team
Aptimmune Biologics announces the addition of Jessica Seate, DVM, as a veterinarian for the company’s swine division. In her new role, Seate will help launch Aptimmune’s new PRRSV and Influenza vaccines made with BARRICADE® formulation technology, as well as assist in the development of the company’s portfolio of swine vaccines. “Dr. Seate’s extensive technical experience in swine vaccine marketing and … Read More
Quarterly Hogs & Pigs Report
The Pork Checkoff hosted the USDA’s Quarterly Hogs and Pigs Report on Thursday, June 29, 2017. This quarterly teleconference featured three agricultural economists and their reactions to the report. Panelists included: Dr. Lee Schulz, Extension Livestock Economist, Iowa State University Dr. Scott Brown, Assistant Extension Professor, University of Missouri-Columbia Joe Kerns, President, Kerns & Associates, Ames, IA Reports seemed to … Read More
A World of First’s in PRRSV Research
The world’s only provider of mucosal PRRSV and flu vaccines, Aptimmue, officially launched during the 2017 World Pork Expo. The vaccine utilizes the BARRICADE proprietary technologies and takes advantage of high-titer PRRSV antigen produced on ZMAC, the world’s only commercially available porcine based alveolar macrophage cell line. During the launch, I sat down with Dr. Jianqiang Zhang, Veterinary Diagnostic Lab, … Read More
Aptimmune Launches World’s First Mucosal PRRSV Vaccine
On opening day of World Pork Expo, Aptimmune Biologics launched the world’s first commercially available mucosal PRRSV vaccine for swine administered via nasal spray. Aptimmune’s autogenous mucosal PRRS vaccine utilizes the BARRICADE® proprietary vaccine technology, which offers producers and veterinarians a revolutionary approach to PRRSV management. The mucosal vaccine offers a new class of vaccine to combat a devastating and … Read More